Abstract: The present invention relates to novel skin-friendly dermally applicable liquid formulations comprising a pyrethrin or pyrethroid and MGK 264 in a ratio of at least 1:20 and a further insecticide, preferably from the group of the neonicotinoids, for controlling parasitic arthropods on animals.

Abstract: This application relates to isotopically labeled affinity markers of the formula (II) for mass spectrometric analysis of proteins. In formula (II), the groups A, PRG, S, Z, L', Z', R, R', k, l, m, and n are as defined in the claims. The application also provides a process for preparing these materials, a method for analyzing proteins using such materials, and a kit containing one or more of these materials.

Abstract: This invention relates to novel phthalamide derivatives of formula (I) wherein R1, R2, R3, R4, and R5 have the meanings given in the disclosure, to processes for their preparation, and to their use as insecticidal agents in agricultural and horticultural field.

Abstract: The present invention provides a process for preparing cyclic 1,3-keto esters in the absence of solvent, using solid-state or high viscosity reactors.

Abstract: An aromatic dihydroxy compound conforming to formula 1 is disclosed. Also disclosed are (co)polycarbonates derived from the compound. The novel (co)polycarbonates are characterized by their reduced water uptake and improved flowability.

Abstract: Method of inhibiting human rhinovirus (HRV) Infection by contacting said HRV with a polypeptide comprising a fragment of human rhinovirus major receptor (HRR), said fragment comprising the HRV binding site and being selected from a specific group consisting of HRR domains.

Abstract: A method of determining the concentration of an analyte in a fluid test sample that includes providing an electrochemical sensor adapted to measure the analyte in the test sample. The test sample sufficiently covers a counter and working electrode of the electrochemical sensor. A first potential is applied between the counter and working electrodes for a first predetermined time period and the current is measured and the time is recorded. After the first potential is removed or substantially reduced, a second potential is applied between the counter and working electrodes and the current is measured. The concentration of the analyte is determined in the test sample as a function of the current measured. An index is calculated and compared to at least one predetermined parameter to identify when a bias, if any, exceeds a threshold. An error signal or analyte concentration is displayed depending on the comparison.

Abstract: The invention relates to quinoxalinones and to methods for producing the same as well as the use thereof for preparing drugs for the treatment and/or prophylaxis of diseases, especially of cardiovascular diseases.

Abstract: The invention relates to methods and compositions for modulating properties of fruit dehiscence in plants such Brassicaceae plants, specifically to improved methods and means for reducing seed shattering in Brassicaceae plants, particularly the Brassicaceae plants grown for oil production, to a degree which is agronomically important.

Abstract: This invention relates to aryl or heteroaryl amido alkane derivatives of formula (I) in which Ar1 and Ar2 independently represent phenyl or a 5 or 6-membered heteroaromatic ring, R6 represents carboxyl or tetrazolyl, and the remaining variables are as defined in the text and claims, which are useful as an active ingredient of pharmaceutical preparations. The aryl or heteroaryl amido alkanes of the present invention have PGI2 antagonistic activity, and can be used for the prophylaxis and treatment of diseases associated with PGI2 activity.

Abstract: The present invention relates to substituted 7H-dibenzo[b,g][1,5]dioxocin-5-one-derivatives, to processes for their preparation and to their use in medicaments, in particular as inhibitors of the cholesterol ester transfer protein (CETP) for the treatment and/or prevention of cardiovascular disorders, in particular hypolipoproteinaemia, dyslipidaemias, hypertriglyceridaemias, hyperlipidaemias and arteriosclerosis.

Abstract: A method for the electrolysis of aqueous solutions of hydrogen chloride in order to produce chlorine, characterized in that the following process parameters are maintained for initial operation: the anode half-element is filled with a 5 to 20% strength by weight hydrochloric acid, the concentration of the hydrochloric acid is more than 5% by weight during initial operation, the volumetric flow of the hydrochloric acid through the anode half-element is set in such a way that, at the start of electrolysis, the velocity of the hydrochloric acid in the anode space is from 0.05 cm/s to 0.15 cm/s, the electrolysis is started with a current density of 0.5 to 2 kA/m2, and the current density is then increased continuously or discontinuously until the desired current density is reached.

Abstract: This application relates to compounds of the formula wherein the groups R1–R6 are as defined in the specification and claims, and to a pharmaceutical composition containing the same, and to a method of using the same in treatment of cardiovascular disorders.

Abstract: Reagents that regulate human aminopeptidase N and reagents which bind to human aminopeptidase N gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, cancer, a CNS disorder or COPD.

Abstract: A process for the isolation of polycarbonate produced by the interfacial polymerization process is disclosed. Accordingly, the process entails (a) evaporating the organic solvent from the solution that contains solvent and polycarbonate to obtain a material system that contains 90 to 99.95% polycarbonate, the percent being relative to the weight of the system, and (b) passing the material system through inlet openings of a separating vessel to obtain a plurality of streams of polycarbonate, on entry into the inlet openings said material system being supersaturated with volatile constituents to an extent of at least 1 bar and having a temperature of 250° to 340° C. and a flow rate of 0.1 to 20 kg/hour, and (c) degassing the streams in the separating vessel wherein the pressure is 0.1 to 20 mbar to effect degassing of the polycarbonate.

Abstract: The invention relates to a novel process for preparing 4,6-dichloro-5-pyrimidine.

Abstract: The present invention relates to gene expression profiles for lung cancer, microarrays comprising nucleic acid sequences representing gene expression profiles, and methods of using expression profiles and microarrays. The invention also provides methods and compositions for diagnostic assays for detecting cancer and therapeutic methods and compositions for treating cancer. The invention also provides methods for designing, identifying, and optimizing therapeutics for cancer.

Abstract: The invention provides a human BG37 which is associated with the disorders of the gastroenterology system, disorders of the peripheral and central nervous system, urology diseases, hematology diseases, cancer diseases, inflammation and cardiovascular diseases. The invention also provides assays for the identification of compounds useful in the treatment or prevention of disorders of the gastroenterology system, disorders of the peripheral and central nervous system, urology diseases, hematology diseases, cancer diseases, inflammation and cardiovascular diseases. The invention also features compounds which bind to and/or activate or inhibit the activity of BG37 as well as pharmaceutical compositions comprising such compounds.

Abstract: The invention relates to heteroaryloxy-substituted phenylaminopyrimidines, to methods for the production thereof, and to the use of the same for producing medicaments for the treatment and/or prophylaxis of diseases, especially cardiovascular diseases. The inventive compounds inhibit Rho-Kinase.

Abstract: Ceramic nanofiltration membrane for use with organic solvents is produced by impregnating a mesoporous ceramic membrane with a hydrophobing agent.